Lara Walkoff MD, Presenter: Nothing to Disclose

Julia Lehman, Abstract Co-Author: Nothing to Disclose

Christopher Harker Hunt MD, Abstract Co-Author: Nothing to Disclose

Geoffrey Bates Johnson MD, PhD, Abstract Co-Author: Nothing to Disclose

Patrick James Peller MD, Abstract Co-Author: Speakers Bureau, General Electric Company

1. Review anatomy and microstructure of the skin with regard to function 2. Discuss optimization of PET/CT for detection of cutaneous pathology 3. Delineate the clinical roles of PET/CT in evaluating primary cutaneous malignancies and metastatic disease to the skin 4. Demonstrate the spectrum of both primary cutaneous diseases and those associated with underlying malignancies with respect to PET/CT imaging findings 5. Illustrate potential pitfalls associated with inflammatory and infectious skin disease 6. Provide radiologic-pathologic correlation for cutaneous malignancies and benign/inflammatory processes

I. Skin Anatomy II. PET/CT optimization for detection of cutaneous processes III. PET/CT imaging of cutaneous disease – radiologic/pathologic correlation a. Malignant: cutaneous T-cell lymphoma, cutaneous B-cell lymphoma, Merkel cell carcinoma, cutaneous angiosarcoma, extramammary Paget’s disease, inflammatory breast cancer b. Benign/Inflammatory: necrobiotic xanthogranuloma, urticarial vasculitis, Sweet syndrome  

http://abstract.rsna.org/uploads/2014/14005342/14005342_vs77.pdf

Walkoff, L, Lehman, J, Hunt, C, Johnson, G, Peller, P, PET/CT Imaging of Cutaneous Diseases.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14005342.html